Viewing Study NCT00942058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-31 @ 11:56 AM
Study NCT ID: NCT00942058
Status: TERMINATED
Last Update Posted: 2014-01-29
First Post: 2009-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Kidney Cancer View
None Metastatic Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None biological markers View
None CA9 protein View
None metastatic conventional renal cell cancer View
None kidney cancer View